Back to SYRE
GEODE CAPITAL MANAGEMENT, LLC → SYRE
GEODE CAPITAL MANAGEMENT, LLC SYRE Position History
Spyre Therapeutics, Inc. • Healthcare
Quarters held
10
Latest value
$27.1M
Q3 2026
Peak value
$214.3M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $18M |
| Q3 2025 | $2.6M |
| Q4 2025 | $47.1M |
| Q4 2025 | $7.3M |
| Q1 2026 | $74.7M |
| Q1 2026 | $12.1M |
| Q2 2026 | $214.3M |
| Q2 2026 | $25M |
| Q3 2026 | $209.4M |
| Q3 2026 | $27.1M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $27.1M | 303.8K | — | — |
| Q3 2026 | $209.4M | 2.25M | — | — |
| Q2 2026 | $25M | 281.5K | — | — |
| Q2 2026 | $214.3M | 2.28M | — | — |
| Q1 2026 | $12.1M | 240.5K | — | — |
| Q1 2026 | $74.7M | 1.48M | — | — |
| Q4 2025 | $7.3M | 222.9K | — | — |
| Q4 2025 | $47.1M | 1.44M | — | — |
| Q3 2025 | $2.6M | 153.5K | — | — |
| Q3 2025 | $18M | 1.07M | — | — |
Other funds holding SYRE
$809.9M
$795.4M
$430.1M
$348.1M
$336.7M
$318.8M